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Summary. Atherosclerosis is the principal cause of 
myocardial infarction, stroke, and peripheral vascular 
disease, accounting for nearly half of all mortality in 
developed countries. For example, it has been estimated 
that atherosclerosis leads to approximately 500,000 
deaths from coronary artery disease and 150,000 deaths 
from stroke every year in the United States (American 
Heart Association, 1996). Percutaneous transluminal 
angioplasty has become a well-established technique for 
revascularization of occluded arteries. However, the 
long-term efficacy of the procedure remains limited by 
progressive vessel renarrowing (restenosis) within the 
following few months after angioplasty. Abnormal 
vascular smooth muscle cell (VSMC) proliferation is 
thought to play an important role in the pathogenesis of 
both atherosclerosis and restenosis. Accordingly, 
considerable effort has been devoted to elucidate the 
mechanisms that regulate cell cycle progression in 
VSMCs. In the present article, we will review the 
different factors that are involved in the control of 
VSMC proliferation, especially in the context of 
cardiovascular disease. Ultimately, a thorough 
understanding of these regulatory networks may lead to 
the development of novel drug and gene therapies for the 
treatment of cardiovascular diseases. Therapeutic 
approaches that targeted specific cell-cycle control genes 
or growth regulatory molecules which effectively 
inhibited neointimal lesion formation will be also 
discussed. 
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by the formation of a neointimal lesion that 
progressively occludes the arterial lumen. Neointimal 
thickening is due to the accumulation of cellular and 
extracellular substances in the space between the 
endothelial cell lining (intima) and the underlying 
medial VSMCs. According to the response-to-injury 
hypothesis, atherosclerosis is triggered by different risk 
factors (hypercholesterolemia, aging, hypertension, 
cigarette smoking and diabetes) that can somehow lead 
to endothelial dysfunction (Ross, 1993). The normal 
endothelium plays numerous physiological roles 
including: 1) provision of a nonthrombogenic, semi- 
permeable surface; 2) regulation of vascular tone by 
release of small molecules that modulate vasodilation 
(nitric oxide, PGI2) or vasoconstriction (endothelin); 3) 
secretion of different growth regulatory molecules and 
cytokines; 4) provision of a nonadherent surface for 
leukocytes and 5 )  ability to modify (oxidize) 
lipoproteins that are transported into the arterial wall. 
Once one or many of these endothelial properties have 
been altered, a succession of events can lead to the 
formation of fatty streaks, the earliest recognizable 
lesion of atherosclerosis, and ultimately to fibrous and 
fibrocalcified plaques. Studies in hypercholesterolemic 
animals and in human atherosclerotic arteries have 
identified three processes involved in the formation of 
the atherosclerotic lesion (Ross, 1993): 1 )  the proli- 
feration of VSMCs, macrophages and possibly lympho- 
cytes; 2) the formation by VSMCs of a connective tissue 
matrix comprising elastic fibre proteins, collagen and 
proteoglycans; and 3) the accumulation of lipid and 
mostly free and esterified cholesterol in the surrounding 
matrix and the associated cells.  VSMCs play the 
principal role in the fibroproliferative component of the 
disease process, because it is the principal source of the 
connective tissue in the arterial wall (Ross, 1993). 
Numerous observations suggest that VSMCs in 
atherosclerotic lesions have changed from a contractile 
to a synthetic state (Campbell and Campbell, 1990). In 
the synthetic state, VSMCs can respond to different 
growth factors and synthetize extracellular matrix 
(Sjolund et al., 1990). "Activated" VSMCs can also 
migrate toward the arterial lumen and express abundant 














